Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs
about
Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolatesThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.Genome Sequencing of Four Multidrug-Resistant Enterobacter aerogenes Isolates from Hospitalized Patients in BrazilClonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil.Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.Intra-abdominal infections: considerations for the use of the carbapenems.The role of carbapenems in initial therapy for serious Gram-negative infections.AmpC beta-lactamases.Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins.Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York.Susceptibilities of common bacterial isolates from oman to old and new antibiotics.Role of porins in sensitivity of Escherichia coli to antibacterial activity of the lactoperoxidase enzyme system.Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae.
P2860
Q34749318-97A59DC2-6606-4207-AE31-AC621C05DBC6Q35482558-800C0EE4-F382-4FC6-940F-69199BA96C29Q35617499-916CFFFB-4BB3-47EC-AFCA-CC9D5A511BADQ35793289-D5C8B4C6-1BBC-4342-A33B-3B8C09C5F29AQ35917401-1F0EC498-116B-40E7-A30E-8AFDE210E054Q36189415-4096941E-0240-4CF2-A99D-D9FA22DC00BBQ36311152-225CAC62-8D51-4E84-87F9-3D381FC8BC98Q36538655-707383C7-149E-4DD6-9424-7439BF5065EFQ36719679-7D89691E-95BC-4AFC-876F-F3A28759FB18Q37169849-011E9E43-1A99-455E-B348-34A661CCEDA4Q37366249-53C7CD4D-B954-4AF8-B0C3-A40158020116Q40882832-C1EA73B6-1A1D-48BE-AC5B-0495ADB3DD73Q41003539-3D301E6A-5393-4597-84CF-9FF322E98534Q41272045-DEAECF86-C937-40DC-AFB7-F6BC689113ADQ42015114-00557622-50E4-43F1-B35D-9E6DACF9E29AQ42772898-0D306467-F302-435D-BEC7-11970EF1EF44
P2860
Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@ast
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@en
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@nl
type
label
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@ast
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@en
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@nl
prefLabel
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@ast
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@en
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@nl
P2093
P2860
P1476
Carbapenem resistance in a cli ...... of OmpF and OmpC porin analogs
@en
P2093
Christine D Steward
Fred C Tenover
Gregory J Anderson
Hesna Yigit
J Kamile Rasheed
James W Biddle
John E McGowan
Lourdes L Valera
P2860
P304
P356
10.1128/AAC.46.12.3817-3822.2002
P407
P577
2002-12-01T00:00:00Z